Megavoltage Computed Tomography in Assessing Placement of Interstitial Brachytherapy Seed Implants in Patients With Prostate Cancer
This trial is active, not recruiting.
|Sponsor||University of Kentucky|
|Start date||March 2013|
|End date||April 2014|
|Trial size||10 participants|
|Trial identifier||NCT01810627, 13-RAD-01|
This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.
|Endpoint classification||efficacy study|
|Intervention model||single group assignment|
Patients will receive an additional MVCT scan at their one month follow up visit.
Change in prostate volume measured in cm^3
time frame: One month post implant
Male participants from 50 years up to 80 years old.
Inclusion Criteria: Male 50-80 years of age Eligible for interstitial brachytherapy implants Exclusion Criteria: -
|Official title||Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma|
|Principal investigator||William St. Clair, MD|
Call for more information